Brain tumor surgery gets a Real-Time upgrade: new test spots hidden cancer cells Mid-Operation
NCT ID NCT07219199
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times
Summary
This study tests a new, ultra-fast lab test (called UR-ddPCR) that can detect leftover IDH1-mutant tumor cells during brain surgery. If the test finds any remaining cancer cells, the surgeon can remove more tissue right away. The goal is to see if this approach helps people with IDH-mutant glioma live longer without their tumor growing back. About 105 adults with newly diagnosed glioma will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.